Please Wait.....
Report
Venous Stents Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 350 Pages I EMR Inc.
The global venous stents market was valued at USD 1.10 Billion in 2024, driven by increasing incidence of venous diseases across the globe. The market is expected to grow at a CAGR of 8.45% during the forecast period of 2025-2034, with the values likely to reach USD 2.48 Billion by 2034.
Global Venous Stents Market Overview
Venous stents are metal mesh-like tubes that expand against narrowed or blocked vein walls in order to maintain the blood flow. These stents are used in the treatment of conditions like chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) to ensure proper blood flow through the affected vein. The market is driven by increasing advancements in venous stent design, rising healthcare expenditure and initiatives to boost awareness around early detection of diseases across the globe.
Global Venous Stents Market Growth Drivers
Increasing Prevalence of Venous Diseases to Affect the Market Landscape Significantly
The increase in prevalence of venous diseases like deep vein thrombosis, venous thromboembolism, and May-Thurner syndrome among others which can be attributed to lifestyle changes and increasing obesity cases in the population is driving growth for venous stents. The economic burden of the disease is also significant due to the cost of medical care.
Adoption of Wallstent Technology to Meet Rising Venous Stents Market Demand
With a rising need to combat venous diseases, the market is witnessing several innovations in products and technology to offer improved solutions to patients. Self-expending stents are taking over the market with the products like Vici, Venovo Venous Stent System, and Abre Venous Self-Expanding Stent System launched by the major market players. Wallstent technology offers multiple advantages such as reduction in complications, improved central venous luminal diameter and provides treatment of symptomatic venous outflow obstruction. Venous Wallstent provides compression resistance as well as fracture resistance. The integration of such technologies is expected to drive market growth and provide a better quality of life to patients.
Global Venous Stents Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Increasing Obesity Rates
Obesity is a major risk for venous diseases, as the body weight can pressurize veins, leading to damage to valves. Along with these, sedentary lifestyle and diabetes can exacerbate the risk of DVT in individuals. In addition, older people are more susceptible to venous conditions due to reduced mobility.
Advancements in Technology
Development of advanced venous stents provides superior performance. They are made more flexible without compromising strength. Incorporation of new materials and coatings are being developed taken into consideration the biocompatibility. To prevent restenosis, drug eluting stents are being developed which locally release drug over a period of time. Bioresorbable stents, intended to be dissolved in the body are also emerging.
Increasing Demand for Minimally Invasive Procedures
There is a shift from traditional open surgeries to minimally invasive surgeries. The shift can be accredited to several benefits such has smaller incisions and faster recovery time. Minimally invasive surgeries also provide reduced risk of complications and pain. Advancements in surgical tools and imaging technology improves efficacy and safety.
Increased Public Awareness
Education campaigns by healthcare personnel and manufacturers targets to educate the public regarding the symptoms and risks associated with venous diseases. Spreading awareness to emphasize the importance and benefit of recognizing signs and early diagnosis to prevent worsening of conditions, along with information around minimally invasive procedures is another market trend.
Global Venous Stents Market Segmentation
Venous Stents Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Iliac Vein Stent Technology
- Wallstent Technology
- Others
Market Breakup by Indication
- Chronic Deep Vein Thrombosis
- Post Thrombotic Syndrome
- May-Thurner Syndrome
- Pelvic Congestion Syndrome (PCS)
- Others
Market Breakup by Application
- Leg
- Chest
- Abdomen
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Cardiac Catheterization Labs
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Venous Stents Market Share
Wallstent Technologies Expected to Lead the Market Share Based on Technology
Based on technology, the market segmentation includes iliac vein stent technology, wallstent technology, and others. Wallstent technology is popular for its high adaptability as well as structural flexibility to venous anatomy and holds a notable market share. Iliac vein stent technology is experiencing rapid growth. The growth is propelled by its vital role in treatment of iliac vein obstruction. It is further fueled by advancements in imaging technologies and procedural techniques which enhances safety and precision of stent placements.
Market Segmentation Based on Disease Areas is Anticipated to Witness Substantial Growth
Based on disease, the market constitutes acute deep vein thrombosis (DVT), chronic DVT/ post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL)/May-Thurner Syndrome (MTS) among others. Out of these, acute DVT is estimated to hold a significant market share. NIVL/MTS is also projected to witness substantial growth, owing to advancements in diagnostic technology which are enhancing the specificity of treatment for the condition. As awareness regarding this conditions rise, the demand for specialized stents is also expected to increase.
Global Venous Stents Market Analysis by Region
On the basis of region, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America boasts an advanced healthcare infrastructure along with presence of key healthcare companies. As a result, it leads the market share. In addition, investments in research and development and medical devices are boosting this region's market growth. Europe follows closely, with growth driven by governmental support for healthcare innovations and growing prevalence of venous conditions. Focus on improving healthcare outcomes and adoption of new technologies are the major factors for the market's expansion.
Leading Players in the Global Venous Stents Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton, Dickinson and Company
- Bentley
- Boston Scientific Corporation
- Cardinal Health
- Cook Group Incorporated
- Koninklijke Philips N.V.
- Medtronic
- W.L Gore & Associates, Inc.
- Shanghai MicroPort Endovascular MedTech (Group)Co., Ltd.
- Jotec GmbH
- Optimed Medizinische Instrumente GmbH
- MicroPort Scientific Corporation
- Medica Germany GMBH & Co.KG
- Cordis Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Venous Stents Market Overview
3.1 Global Venous Stents Market Historical Value (2018-2024)
3.2 Global Venous Stents Market Forecast Value (2025-2034)
4 Global Venous Stents Market Landscape*
4.1 Global Venous Stents Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Venous Stents Market: Product Landscape
4.2.1 Analysis by Detection Target
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Venous Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Venous Stents Market Segmentation (218-2034)
6.1 Global Venous Stents Market (2018-2034) by Technology
6.1.1 Market Overview
6.1.2 Iliac Vein Stent Technology
6.1.3 Wallstent Technology
6.1.4 Others
6.2 Global Venous Stents Market (2018-2034) by Indication
6.2.1 Market Overview
6.2.2 Chronic Deep Vein Thrombosis
6.2.3 Post-Thrombotic Syndrome (PTS)
6.2.4 May-Thurner's Syndrome
6.2.5 Pelvic Congestion Syndrome (PCS)
6.2.6 Others
6.3 Global Venous Stents Market (2018-2034) by Application
6.3.1 Market Overview
6.3.2 Leg
6.3.3 Chest
6.3.4 Abdomen
6.3.5 Others
6.4 Global Venous Stents Market (2018-2034) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgery Centers
6.4.4 Specialty Clinics
6.4.5 Cardiac Catheterization Labs
6.4.6 Others
6.5 Global Venous Stents Market (2018-2034) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Venous Stents Market (218-2034)
7.1 North America Venous Stents Market (2018-2034) by Technology
7.1.1 Market Overview
7.1.2 Iliac Vein Stent Technology
7.1.3 Wallstent Technology
7.1.4 Others
7.2 North America Venous Stents Market (2018-2034) by Indication
7.2.1 Market Overview
7.2.2 Chronic Deep Vein Thrombosis
7.2.3 Post-Thrombotic Syndrome (PTS)
7.2.4 May-Thurner's Syndrome
7.2.5 Pelvic Congestion Syndrome (PCS)
7.2.6 Others
7.3 North America Venous Stents Market (2018-2034) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Venous Stents Market (218-2034)
8.1 Europe Venous Stents Market (2018-2034) by Technology
8.1.1 Market Overview
8.1.2 Iliac Vein Stent Technology
8.1.3 Wallstent Technology
8.1.4 Others
8.2 Europe Venous Stents Market (2018-2034) by Indication
8.2.1 Market Overview
8.2.2 Chronic Deep Vein Thrombosis
8.2.3 Post-Thrombotic Syndrome (PTS)
8.2.4 May-Thurner's Syndrome
8.2.5 Pelvic Congestion Syndrome (PCS)
8.2.6 Others
8.3 Europe Venous Stents Market (2018-2034) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Venous Stents Market (218-2034)
9.1 Asia Pacific Venous Stents Market (2018-2034) by Technology
9.1.1 Market Overview
9.1.2 Iliac Vein Stent Technology
9.1.3 Wallstent Technology
9.1.4 Others
9.2 Asia Pacific Venous Stents Market (2018-2034) by Indication
9.2.1 Market Overview
9.2.2 Chronic Deep Vein Thrombosis
9.2.3 Post-Thrombotic Syndrome (PTS)
9.2.4 May-Thurner's Syndrome
9.2.5 Pelvic Congestion Syndrome (PCS)
9.2.6 Others
9.3 Asia Pacific Venous Stents Market (2018-2034) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Venous Stents Market (218-2034)
10.1 Latin America Venous Stents Market (2018-2034) by Technology
10.1.1 Market Overview
10.1.2 Iliac Vein Stent Technology
10.1.3 Wallstent Technology
10.1.4 Others
10.2 Latin America Venous Stents Market (2018-2034) by Indication
10.2.1 Market Overview
10.2.2 Chronic Deep Vein Thrombosis
10.2.3 Post-Thrombotic Syndrome (PTS)
10.2.4 May-Thurner's Syndrome
10.2.5 Pelvic Congestion Syndrome (PCS)
10.2.6 Others
10.3 Latin America Venous Stents Market (2018-2034) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Venous Stents Market (218-2034)
11.1 Middle East and Africa Venous Stents Market (2018-2034) by Technology
11.1.1 Market Overview
11.1.2 Iliac Vein Stent Technology
11.1.3 Wallstent Technology
11.1.4 Others
11.2 Middle East and Africa Venous Stents Market (2018-2034) by Indication
11.2.1 Market Overview
11.2.2 Chronic Deep Vein Thrombosis
11.2.3 Post-Thrombotic Syndrome (PTS)
11.2.4 May-Thurner's Syndrome
11.2.5 Pelvic Congestion Syndrome (PCS)
11.2.6 Others
11.3 Middle East and Africa Venous Stents Market (2018-2034) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Component of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Product
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Component of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Component of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Becton, Dickinson and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bentley
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Boston Scientific Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cardinal Health
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cook Group Incorporated
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Koninklijke Philips N.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medtronic
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 W.L Gore & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Shanghai MicroPort Endovascular MedTech (Group)Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Jotec GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Optimed Medizinische Instrumente GmbH
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 MicroPort Scientific Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Medica Germany GMBH & Co.KG
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Cordis Inc.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Venous Stents Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security